Assaker MedCorp: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Assaker MedCorp
Largest movements
- Deferred charges and accrued income +€46,787
up €46,787 (+384%), from €12,183 to €58,969
- Cash +€34,588
up €34,588 (+284%), from €12,158 to €46,746
mainly Net result for the year (+€79,140) and Tax, wage and social debts (+€23,928)
- Tangible fixed assets +€13,352
new in 2025: €13,352
- Receivables within one year +€8,642
up €8,642 (+43,212%), from €20 to €8,662
- Reserves +€79,140
up €79,140 (+453%), from €17,463 to €96,604
- Tax, wage and social debts +€23,928
up €23,928 (+546%), from €4,384 to €28,312
- Gross operating margin +€86,222
up €86,222 (+394%), from €21,873 to €108,095
- Taxes +€17,099
up €17,099 (+390%), from €4,384 to €21,483
- Depreciation +€6,648
new in 2025: €6,648
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €24,361 | €127,730 | +€103,369 | +424% |
| Fixed assets | 21/28 | - | €13,352 | +€13,352 | |
| Tangible fixed assets | 22/27 | - | €13,352 | +€13,352 | |
| Furniture and vehicles | 24 | - | €13,352 | +€13,352 | |
| Current assets | 29/58 | €24,361 | €114,378 | +€90,017 | +370% |
| Amounts receivable within one year | 40/41 | €20 | €8,662 | +€8,642 | +43,212% |
| Other amounts receivable | 41 | €20 | €8,662 | +€8,642 | +43,212% |
| Cash at bank and in hand | 54/58 | €12,158 | €46,746 | +€34,588 | +284% |
| Deferred charges and accrued income | 490/1 | €12,183 | €58,969 | +€46,787 | +384% |
| Total equity and liabilities | 10/49 | €24,361 | €127,730 | +€103,369 | +424% |
| Equity | 10/15 | €18,963 | €98,104 | +€79,140 | +417% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €17,463 | €96,604 | +€79,140 | +453% |
| Distributable reserves | 133 | €17,463 | €96,604 | +€79,140 | +453% |
| Amounts payable | 17/49 | €5,397 | €29,626 | +€24,229 | +449% |
| Amounts payable within one year | 42/48 | €5,397 | €29,626 | +€24,229 | +449% |
| Trade debts | 44 | €1,013 | €1,314 | +€301 | +29.7% |
| Suppliers | 440/4 | €1,013 | €1,314 | +€301 | +29.7% |
| Taxes, remuneration and social security | 45 | €4,384 | €28,312 | +€23,928 | +546% |
| Taxes | 450/3 | €4,384 | €28,312 | +€23,928 | +546% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €6,648 | +€6,648 | |
| Other operating charges | 640/8 | - | €683 | +€683 | |
| Gross operating margin | 9900 | €21,873 | €108,095 | +€86,222 | +394% |
| Operating profit (loss) | 9901 | €21,873 | €100,764 | +€78,891 | +361% |
| Financial charges | 65/66B | €25 | €140 | +€115 | +453% |
| Recurring financial charges | 65 | €25 | €140 | +€115 | +453% |
| Profit (loss) for the period before taxes | 9903 | €21,848 | €100,624 | +€78,776 | +361% |
| Income taxes | 67/77 | €4,384 | €21,483 | +€17,099 | +390% |
| Profit (loss) for the period | 9904 | €17,463 | €79,140 | +€61,677 | +353% |
| Profit (loss) for the period to be appropriated | 9905 | €17,463 | €79,140 | +€61,677 | +353% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.